Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

• Christoph Jindra,

  Current address: Veterinary University of Vienna, Vienna, Austria

  Affiliation Laboratory of Viral Oncology (LVO), Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Bettina Huber,

  Affiliation Laboratory of Viral Oncology (LVO), Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Saeed Shafti-Keramat,

  Affiliation Laboratory of Viral Oncology (LVO), Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯
• Markus Wolschek,

  Affiliations Research Group Oncology (RGO), Equine Clinic, Veterinary University of Vienna, Vienna, Austria, Bluesky Vaccines, Vienna, Austria

  ⨯
• Boris Ferko,

  Current address: HSC development GmbH, Vienna, Austria

  Affiliation Bluesky Vaccines, Vienna, Austria

  ⨯
• Thomas Muster,

  Affiliation Bluesky Vaccines, Vienna, Austria

  ⨯
• Sabine Brandt,

  Affiliation Research Group Oncology (RGO), Equine Clinic, Veterinary University of Vienna, Vienna, Austria

  ⨯
• Reinhard Kirnbauer

  * E-mail: reinhard.kirnbauer@meduniwien.ac.at

  Affiliation Laboratory of Viral Oncology (LVO), Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, Austria

  ⨯